BioSpace News Archive

Business

Endo Announces Appointment of Dr. Sharad S. Mansukani to Board of Directors and Resignation of Mr. Douglas S. Ingram

Ingram’s decision to resign as a director from the Company’s Board of Directors effective November 6, 2017 is due to his appointment as President and CEO of Sarepta Therapeutics earlier this year.

November 8, 2017
·
4 min read
Business

Phagelux Announces a Multi-Product Collaboration With Passport Food Safety Solutions

Phagelux’s U.S. operating division has entered into an agreement to develop for Passport Food Safety four bacteriophage-based products to be used for a variety of food safety and environment protection purposes.

November 8, 2017
·
2 min read
Business

Novus Therapeutics Reports Third Quarter 2017 Results

For the third quarter of 2017, Novus reported a net loss of $3.0 million, or $0.43 loss per share, compared to a net loss of $2.0 million, or $4.35 loss per share, for the same period in 2016.

November 8, 2017
·
16 min read
Lone Star Bio

DisperSol Technologies Announces New R&D Data to Be Presented at 2017 Annual Meeting of AAPS

The symposium will highlight partners’ experiences with KinetiSol: a novel manufacturing technology for making amorphous solid dispersions of poorly water-soluble drug molecules to enhance their bioavailability & clinical effectiveness.

November 8, 2017
·
2 min read
Business

Aeterna Zentaris Reports Third Quarter 2017 Financial and Operating Results

Revenues were $241,000 and $745,000 for the three and nine months ended September 30, 2017, as compared to $269,000 and $607,000 for the same periods in 2016.

November 8, 2017
·
13 min read